LYN and chronic myelogenous leukemia, BCR-ABL1 positive: Based on a tyrosine phosphoproteomic analysis, Gioia et al. observed increased phosphorylation of Lyn and Syk kinase in nilotinib-resistant chronic myeloid leukemia (CML) cells.